Funded Tech Companies

Emmecell

Emmecell, operating out of Menlo Park, received equity investments from Bausch & Lomb.

Company Overview

Company Name
Emmecell
Company Status
Private & Independent
Funding Rounds
Total Funding

Contact Information

Mailing Address
3475 Edison Way T
Menlo Park, CA 94025
USA
Phone
Undisclosed
Email Address

Company Background Information

Overview
Emmecell is a clinical-stage biotechnology company developing cell-based therapies for eye diseases using its proprietary Magnetic Cell Delivery (MCD) nanoparticle platform. Headquartered in Menlo Park, California, the company focuses on minimally invasive, regenerative alternatives to traditional surgeries for conditions like corneal edema and macular degeneration.
Profile
Emmecell LinkedIn Company Profile
Social Media
Emmecell Company Twitter Account
Company News
Emmecell News
Facebook
Emmecell on Facebook
YouTube
Emmecell on YouTube
Last Transaction
6/17/2026

Financing History

Date
Type
Amount
Venture Equity
Unknown


Management Team

Title
Name
Email & Social
Chairman
Jeffrey Goldberg
  Jeffrey Goldberg LinkedIn Profile  Jeffrey Goldberg Twitter Account  Jeffrey Goldberg News  Jeffrey Goldberg on Facebook
Chief Executive Officer
Ramin Valian
  Ramin Valian LinkedIn Profile  Ramin Valian Twitter Account  Ramin Valian News  Ramin Valian on Facebook
Chief Operating Officer
Noelia Kunzevitzky
  Noelia Kunzevitzky LinkedIn Profile  Noelia Kunzevitzky Twitter Account  Noelia Kunzevitzky News  Noelia Kunzevitzky on Facebook
Co-Founder
Roger Goldberg
  Roger Goldberg LinkedIn Profile  Roger Goldberg Twitter Account  Roger Goldberg News  Roger Goldberg on Facebook


Company Investors

  • Bausch & Lomb

 

 

 

Browse more funded tech companies:

Emme Health | Emmersion Learning

 

Share this article

 


About Our Venture Capital Database

Our data comes from VentureDeal.com, a leading provider of venture capital transaction data.

 


Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary